Log In
Print this Print this

NeoBase (NeoBase test)

  Manage Alerts
Collapse Summary General Information
Company PerkinElmer Inc.
DescriptionBlood-based neonate test that uses the Succinylacetone marker to detect Tyrosinemia Type I
Molecular Target
Mechanism of ActionDiagnostic
Therapeutic ModalityDiagnostics
Latest Stage of DevelopmentMarketed
Standard IndicationMetabolic, Diagnostic
Indication DetailsDetect hereditary tyrosinemia type I
Regulatory Designation

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today